UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The transcriptional modulator BCL6 as a molecular target for breast cancer therapy

Oncogene, 2015-02, Vol.34 (9), p.1073-1082

2015

Volltextzugriff (PDF)

PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS

Hematological oncology, 2023-06, Vol.41 (S2), p.848-849

2023

Volltextzugriff (PDF)

Performance of TXRF among other competitors' analytical techniques

X-ray spectrometry, 2020-05, Vol.49 (3), p.374-378

2020

Volltextzugriff (PDF)

MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.560-561

2019

Volltextzugriff (PDF)

Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced Cancer

Journal of pain and symptom management, 2006, Vol.31 (1), p.38-47

2006

Volltextzugriff (PDF)

DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation

Blood, 2011-09, Vol.118 (13), p.3559-3569

2011

Volltextzugriff (PDF)

17P BCL6 and Notch pathway: A signaling axis leading to a novel druggable biotarget in triple-negative breast cancer

Annals of oncology, 2021-03, Vol.32, p.S8-S8

2021

Volltextzugriff (PDF)

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells

Nature medicine, 2004-12, Vol.10 (12), p.1329-1335

2004

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.848

2023

Volltextzugriff (PDF)

Kaiso-Deficient Mice Show Resistance to Intestinal Cancer

Molecular and Cellular Biology, 2006-01, Vol.26 (1), p.199-208

2006

Volltextzugriff (PDF)

Morphine mouthwashes for painful mucositis

Supportive care in cancer, 2007-01, Vol.15 (1), p.115-116

Cerchietti, Leandro

2007

Volltextzugriff (PDF)

Hypodermoclysis for control of dehydration in terminal-stage cancer

International journal of palliative nursing, 2000-09, Vol.6 (8), p.370-374

2000

Volltextzugriff (PDF)

Abstract P1-07-02: Withdrawn

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-07-02

2019

Volltextzugriff (PDF)

Response to Second-line Therapy Defines the Potential for Cure in Patients With Recurrent Diffuse Large B-Cell Lymphoma: Implications for the Development of Novel Therapeutic Strategies

Clinical lymphoma, myeloma and leukemia, 2010-06, Vol.10 (3), p.192-196

2010

Volltextzugriff (PDF)

Le Midazolam comme thérapeutique adjuvante de la Morphine dans le contrôle de la perception de la dyspnée sévère chez les patients présentant un cancer avancé

Médecine palliative, 2006-09, Vol.5 (4), p.219-219

2006

Volltextzugriff (PDF)

Quantification of Pu in aerosols released from nuclear power plants

Journal of radioanalytical and nuclear chemistry, 2007-10, Vol.274 (1), p.9-13

2007

Volltextzugriff (PDF)

Oral morphine versus oral midazolam as upfront therapy to relief dyspnea in ambulatory cancer patients while its underlying cause is sought or treated

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9585-9585

2008

Volltextzugriff (PDF)

Quantification of 241Pu in aerosols released from nuclear power plants

Journal of radioanalytical and nuclear chemistry, 2007-10, Vol.274 (1), p.9-13

2007

Volltextzugriff (PDF)

Quantification of super(241)Pu in aerosols released from nuclear power plants

Journal of radioanalytical and nuclear chemistry, 2007-10, Vol.274 (1), p.1-5

2007

Volltextzugriff (PDF)

Late toxicity in head and neck cancer (H&N) patients (pts) treated with hyperfractionated (HF) or accelerated (AC) radiotherapy (RT) and chemotherapy (CT)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5610-5610

2004

Volltextzugriff (PDF)

Late toxicity in head and neck cancer (H&N) patients (pts) treated with hyperfractionated (HF) or accelerated (AC) radiotherapy (RT) and chemotherapy (CT)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5610-5610

2004

Volltextzugriff (PDF)

Inhibition of Tumor Progression and Paraneoplastic Syndrome Development in a Murine Lung Adenocarcinoma by Medroxyprogesterone Acetate and Indomethacin

Cancer investigation, 2006-03, Vol.24 (2), p.126-131

2006

Volltextzugriff (PDF)

A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo

Cancer cell, 2010-04, Vol.17 (4), p.400-411

2010

Volltextzugriff (PDF)

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

The Journal of clinical investigation, 2016-09, Vol.126 (9), p.3351-3362

2016

Volltextzugriff (PDF)

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas

Nature medicine, 2009-12, Vol.15 (12), p.1369-1376

2009

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(65)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(25)
Life Sciences & Biomedicine
(23)
Cell Line, Tumor
(13)
Animals
(12)
Mice
(10)
Oncology
(10)
Female
(8)
Male
(8)
Biochemistry & Molecular Biology
(7)
Cell Biology
(7)
Lymphoma
(7)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(7)
Proteins
(7)
Cancer
(6)
Hematology
(6)
Mice, Inbred C57bl
(6)
Apoptosis
(5)
Care And Treatment
(5)
Gene Expression
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The transcriptional modulator BCL6 as a molecular target for breast cancer therapy

PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS

Performance of TXRF among other competitors' analytical techniques

MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA

Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced Cancer

DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation

17P BCL6 and Notch pathway: A signaling axis leading to a novel druggable biotarget in triple-negative breast cancer

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Kaiso-Deficient Mice Show Resistance to Intestinal Cancer

Morphine mouthwashes for painful mucositis

Hypodermoclysis for control of dehydration in terminal-stage cancer

Abstract P1-07-02: Withdrawn

Response to Second-line Therapy Defines the Potential for Cure in Patients With Recurrent Diffuse Large B-Cell Lymphoma: Implications for the Development of Novel Therapeutic Strategies

Le Midazolam comme thérapeutique adjuvante de la Morphine dans le contrôle de la perception de la dyspnée sévère chez les patients présentant un cancer avancé

Quantification of Pu in aerosols released from nuclear power plants

Oral morphine versus oral midazolam as upfront therapy to relief dyspnea in ambulatory cancer patients while its underlying cause is sought or treated

Quantification of 241Pu in aerosols released from nuclear power plants

Quantification of super(241)Pu in aerosols released from nuclear power plants

Late toxicity in head and neck cancer (H&N) patients (pts) treated with hyperfractionated (HF) or accelerated (AC) radiotherapy (RT) and chemotherapy (CT)

Late toxicity in head and neck cancer (H&N) patients (pts) treated with hyperfractionated (HF) or accelerated (AC) radiotherapy (RT) and chemotherapy (CT)

Inhibition of Tumor Progression and Paraneoplastic Syndrome Development in a Murine Lung Adenocarcinoma by Medroxyprogesterone Acetate and Indomethacin

A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas

Suchergebnisse filtern